- Home
- MRK vs TSLA Comparison
MRK vs TSLA Comparison
Compare MRK & TSLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | TSLA |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 1.5T |
| IPO Year | 1997 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MRK | TSLA |
|---|---|---|
| Price | $148.78 | $376.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 44 |
| Target Price | $158.44 | ★ $397.83 |
| AVG Volume (30 Days) | 6.0M | ★ 27.0M |
| Earning Date | 10-29-2026 | 10-21-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ 0.67 |
| Revenue | $65,011,000,000.00 | ★ $94,827,000,000.00 |
| Revenue This Year | $3.12 | $13.03 |
| Revenue Next Year | $4.31 | $13.52 |
| P/E Ratio | ★ N/A | $858.37 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $82.01 | $297.38 |
| 52 Week High | $157.00 | $498.83 |
Technical Indicators
Market Signals| Indicator | MRK | TSLA |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 55.85 |
| Support Level | $145.75 | $366.31 |
| Resistance Level | $154.46 | $386.48 |
| Average True Range (ATR) | 4.33 | 10.50 |
| MACD | 0.40 | 0.49 |
| Stochastic Oscillator | 59.56 | 78.40 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About TSLA Tesla Inc.
Tesla is a vertically integrated battery electric vehicle automaker and developer of real-world artificial intelligence software, which includes autonomous driving and humanoid robots. The company has multiple vehicles in its fleet, which include a midsize sedan and crossover SUV in the entry-level luxury category, a luxury light truck, and a semitruck. Tesla also runs a robotaxi service in four US metropolitan areas. Global deliveries in 2025 were nearly 1.64 million vehicles. Additionally, the company sells batteries for stationary storage for residential and commercial properties, including utilities, solar panels, and solar roofs for energy generation. Tesla also owns a fast-charging network and a US auto insurance business.